β细胞数量减少而非体积缩小是2型糖尿病β细胞丢失的主要因素
该研究基于64例接受胰腺切除术的日本成人(26例2型糖尿病,38例无糖尿病),通过胰岛素染色评估β细胞体积和数量。结果显示2型糖尿病患者的β细胞体积和数量均显著降低,但数量相对减少(37%)大于体积减少(10%),且β细胞数量与β细胞质量正相关、与HbA1c负相关,提示β细胞数量减少是2型糖尿病β细胞质量下降的主要贡献因素。
要点
- 2型糖尿病患者β细胞数量减少37%,体积减少10%,数量减少更显著。
- β细胞数量与β细胞质量强正相关(r=0.97~0.98),体积无此相关性。
- β细胞数量与HbA1c负相关(r=-0.45),提示数量减少与血糖控制恶化相关。
核心结论
- 2型糖尿病患者β细胞体积和数量均减少,但数量相对减少更大,数量减少是β细胞质量下降的主要贡献因素。
研究设计与样本
- 研究纳入64例日本成人(26例2型糖尿病,38例无糖尿病)接受胰腺切除术的胰腺样本,采用胰岛素染色评估β细胞形态。
主要发现
- 2型糖尿病组β细胞体积为548.7 ± 58.5 μm3,非糖尿病组为606.7 ± 65.0 μm3(p < 0.01)。
- 2型糖尿病组β细胞数量为5.10 × 108 ± 2.35 × 108,非糖尿病组为8.16 × 108 ± 4.27 × 108(p < 0.01)。
- β细胞数量相对减少37%,体积相对减少10%。
- 在有和无2型糖尿病的参与者中,β细胞数量与β细胞质量正相关(r = 0.97和r = 0.98,均p < 0.01),体积无此相关性。
- β细胞数量与HbA1c负相关(r = -0.45,p < 0.01)。
临床怎么用
- 评估2型糖尿病β细胞功能时,应关注β细胞数量减少而非仅体积变化,数量减少与血糖控制恶化相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Type 2 diabetes is characterised by reduced beta cell mass (BCM). However, it remains uncertain whether the reduction in BCM in type 2 diabetes is due to a decrease in size or number of beta cells. Our aim was to examine the impact of beta cell size and number on islet morphology in humans with and without type 2 diabetes. METHODS: Pancreas samples were obtained from 64 Japanese adults with (n = 26) and without (n = 38) type 2 diabetes who underwent pancreatectomy. Using pancreatic tissues stained for insulin, we estimated beta cell size based on beta cell diameter. Beta cell number was estimated from the product of fractional beta cell area and pancreas volume divided by beta cell size. The associations of beta cell size and number with islet morphology and metabolic status were examined. RESULTS: Both beta cell size (548.7 ± 58.5 vs 606.7 ± 65.0 μm3, p < 0.01) and number (5.10 × 108 ± 2.35 × 108 vs 8.16 × 108 ± 4.27 × 108, p < 0.01) were decreased in participants with type 2 diabetes compared with those without diabetes, with the relative reduction in beta cell number (37%) being greater than for beta cell size (10%). Beta cell number but not size was positively correlated with BCM in participants with and without type 2 diabetes (r = 0.97 and r = 0.98, both p < 0.01) and negatively correlated with HbA1c (r = -0.45, p < 0.01). CONCLUSIONS/INTERPRETATION: Both beta cell size and number were reduced in participants with type 2 diabetes, with the relative reduction in beta cell number being greater. Decrease in beta cell number appears to be a major contributor to reduced BCM in type 2 diabetes.
引用
- Sasaki H, Saisho Y, Inaishi J, et al. Reduced beta cell number rather than size is a major contributor to beta cell loss in type 2 diabetes. Diabetologia. 2021. PMID: 33938968. doi:10.1007/s00125-021-05467-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。